Rifapentine Tablet, Film Coated
Brand names: Priftin
Category: Anti-Infective
FDA status: Resolved · Last FDA update: Aug 6, 2026 · First posted: Mar 25, 2020 · 1 manufacturers, 1 listed presentations
As of Aug 6, 2026, the FDA lists Rifapentine Tablet, Film Coated as shortage resolved. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Priftin, Tablet, Film Coated, 150 mg (NDC 0088-2102-24) NDC 0088-2102-24 |
Sanofi-Aventis U.S. LLC | Not specified | - |
Related medications in shortage
Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Rifapentine Tablet, Film Coated (FDA data as of Aug 6, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Rifapentine Tablet, Film Coated. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/rifapentine-tablet-film-coated.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).